Why Warp Sciences thinks chemistry needs robot lab hands
Kevin Weil and Sol Reisberg explain the engineering bottleneck that pushed them…
Warhound’s cloned military dogs arrive long before the kennel does
Warhound left stealth with $200M in seed money at a $1.2B valuation…
Three European biotech founders on moving cancer science to patients
Three French deeptech founders compare notes on taking cancer therapies from the…
A Basel biotech bets $135M that a vaccine can stop cancer early
Nouscom closed an oversubscribed $135M Series D to run a registration-enabling trial…
Sheffield spin-out Silvia Bio raises £3M to fix misbehaving cells
Northern Gritstone led a seed round for a biotech that diagnoses why…
Microbiotica raises EUR 42M to engineer gut bacteria drugs
British Business Bank led a Series C first close for the Cambridge…
AstraZeneca bets up to $1.5B that machine learning can find liver drugs
The pharma major is tying a biobucks-heavy collaboration to insitro's models for…
Can anyone actually trust an AI scientist in the lab
LatchBio CTO Kenny Workman explains how his team turns real biology workflows…
Oxford spin-out OMass collects €275M for stubborn drug targets
OMass Therapeutics closed an oversubscribed €275M Series C to push small-molecule medicines…
Why chemists can only reach a sliver of possible molecules
An Onepot researcher explains how machine learning is opening up the chemical…
